지난 1월 이뮨메드 HzVSF는 식품의약안전처로부터 '임상시험용의약품 치료목적 사용승인'을 받았다.
In January, ImmuneMed HzVSF received approval from the Ministry of Food and Drug Safety for use in clinical trial drugs for therapeutic purposes.